Antineoplastics

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level 

 Molecularly targeted agents
 
 Hormones and hormone antagonist
 
 Biologic response modifiers
 
 Alkylating agents
 
 Antimetabolites
 
 Natural products
 
 Miscellaneous agents
   Adrenocortical suppressant
   Bisphosphonates
   Cytoprotector (reactive species antagonists)
   Methylhydrazine derivative
   Platelet-reducing agent
   Salt
   Somatostatin analog
   Substituted melanine
   Substitued urea
   Sensitizers used in photodynamic/radiation therapy
   Other antineoplastic agents
     Amascrine [ATC:L01XX01]
     Lonidamine [ATC:L01XX07]
     Miltefosine [ATC:L01XX09]
     Masprocol [ATC:L01XX10]
     Mitoguazone [ATC:L01XX16]
     Tiazofurine [ATC:L01XX18]
     Alitretinoin [ATC:L01XX22]
     Pegaspargase [ATC:L01XX24]
     Bexarotene [ATC:L01XX25]
     Celecoxib [ATC:L01XX33]
     Oblimersen [ATC:L01XX36]
       D08290  Oblimersen (INN)
       D05216  Oblimersen sodium (USAN)
     Sitimagene ceradenovec [ATC:L01XX37]
     Vorinostat [ATC:L01XX38]
     Romidepsin [ATC:L01XX39]
     Omacetaxine [ATC:L01XX40]
     Panobinostat [ATC:L01XX42]

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: May 15, 2014

» Japanese version